Metal Implant Patients Should Get Blood Tests, Australia Says

Law360, New York (September 24, 2012, 8:19 PM EDT) -- An Australian regulator recommended Thursday that all recipients of metal-on-metal hip implants regularly have their blood tested for the presence of cobalt and chromium, two ions whose health effects are at issue in U.S. litigation over the devices.

Doctors should monitor the cobalt and chromium levels of implant recipients, regardless of whether they present with thigh pain and other symptoms usually associated with elevated levels of the ions, the Therapeutic Goods Administration said.

There is no definitive link between cobalt and chromium released from metal-on-metal implants...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.